The global non-surgical fat reduction market is poised for significant growth, with its valuation expected to rise from USD 1700.5 million in 2024 to an impressive USD 2932.3 million by 2034. This represents a robust compound annual growth rate (CAGR) of 5.6% over the forecast period.
Non-surgical fat reduction treatments have gained popularity due to their minimally invasive nature, offering patients effective solutions for body contouring without the downtime or risks associated with surgical procedures. Technologies such as cryolipolysis, ultrasound, and laser-based treatments are increasingly being adopted in aesthetic clinics worldwide, driving the expansion of the market.
This growing demand is attributed to several factors, including rising consumer awareness of non-invasive cosmetic treatments, increasing disposable income, and advancements in fat reduction technologies that provide better results with fewer side effects.
Industry experts predict that this growth trend will continue as technological innovations and increasing investments in the cosmetic industry further expand treatment options for individuals seeking safe and effective fat reduction solutions without surgery.
Key Takeaways from the Market Study:
- From 2019 to 2023, the non surgical fat reduction market expanded at a CAGR of 10.30%.
- Based on the technique, the cryolipolysis segment is expected to account for a market share of 33.50%
- The demand for non surgical fat reduction in the Germany is predicted to grow at a CAGR of 3.10% through 2034.
- In the United States, the non surgical fat reduction industry is estimated to register a CAGR of 1.7% from 2024 to 2034.
- China is projected to expand by a CAGR of 1.8% between 2024 and 2034.
- The non surgical fat reduction market in Japan is anticipated to record a CAGR of 0.90% during 2034.
“The Increasing demand for minimally invasive body contouring procedures and rising obesity rates drive the nonsurgical fat reduction market,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Competitive Landscape:
The market players in the nonsurgical fat reduction market are investing in research and development to create innovative nonsurgical fat reduction techniques that offer improved results, shorter treatment time, and enhanced patient comfort. The market layers are collaborating with healthcare providers, aesthetic clinics and distribution partner to expand their market reach.
- In January2021 – Allergan Aesthetics has announced the release of CoolSculpting® Elite, a next-generation fat-loss technology whose applicators enhance the body’s natural contours. Targeting, freezing, and eradicating treated fat cells is possible with CoolSculpting® Elite because to its proven CoolSculpting® technology.
- The FDA has approved CoolSculpting® Elite to treat noticeable fat bulges in nine different body sites, including the flank, thigh, and abdomen; bra fat, back fat, upper arm, beneath the buttocks (sometimes called the banana roll); and the submental and submandibular regions.
Non-Surgical Fat Reduction Market Trends: Discover the Full Details in Our Extensive Report!
Key Companies Profiled:
- Valeant Pharmaceuticals International Inc.
- Allergan plc
- Alma Lasers
- Cynosure, Inc.
- Sciton, Inc.
- Solta Medical Inc.
- Lumenis Ltd.
- Syneron Medical Ltd.
- Lutronic Corporation
- Lynton Lasers Ltd.
- Cutera Inc.
Key Market Segments Covered in the Non Surgical Fat Reduction Industry Research:
By Technique:
- Cryolipolysis
- Ultrasound
- Low-Level Lasers
- Others
By End User:
- Hospitals
- Plastic Surgery Centers
- Cosmetic and Aesthetic Clinics
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The weight loss and obesity management market size is projected to rise at a CAGR of 12.8% during the projected period. The market value is projected to increase from USD 14,511 million in 2024 to USD 48,396 million by 2034.
The obesity management market share is expected to expand with a CAGR of 5.2% during the forecast period from 2023 to 2033. The overall market value is projected to grow from USD 2,095.6 million in 2023 to USD 3,494.5 million by 2033.
The body fat reduction market demand is expected to expand its roots at a steady CAGR of 9.6% during the forecast period. The market is likely to hold a revenue of USD 10.65 billion in 2023 while it is anticipated to cross a value of USD 25.6 billion by 2033.
The global HIV diagnostics market growth is estimated to be worth USD 3,497.2 million in 2024 and anticipated to reach a value of USD 7,207.7 million by 2034. Sales are projected to rise at a CAGR of 7.5% over the forecast period between 2024 and 2034.
The contact-lens induced infections market outlook is estimated to reach USD 491.3 million in 2024. It is estimated that revenue will increase at a CAGR of 4.9% between 2024 and 2034. The market is anticipated to reach USD 792.6 million by 2034.
The self-administered biologics market overview is estimated to reach USD 94,057.6 million in 2024. It is estimated that revenue will increase at a CAGR of 4.5% between 2024 and 2034. The market is anticipated to reach USD 146,068.5 million by 2034.
The global patient transportation market sales is estimated to be worth USD 22,035.5 million in 2024 and anticipated to reach a value of USD 37,639.9 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034.
The global vascular patches market forecast is estimated to be worth USD 160.3 million in 2024 and anticipated to reach a value of USD 256.2 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034.
The MENA syringes & cannula market opportunity are estimated to be worth USD 1,592.2 million in 2024 and are anticipated to reach a value of USD 2,824.7 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
The carbon dioxide incubators market strategies is estimated to reach USD 752.9 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated to reach USD 1,238.1 million by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
